Mounjaro is the first and only GIP and GLP-1 receptor agonist proven to lower heart attack, stroke or cardiovascular death risk in adults with type 2 diabetes at high risk for these events – in ...
Mounjaro is the first and only GIP and GLP-1 receptor agonist proven to lower heart attack, stroke or cardiovascular death risk in adults with type 2 diabetes at high ...
South Africa’s first generic semaglutide injection arrived in August, with many more expected. Increased competition should ...
Daily Maverick on MSN
The first generic weight loss drug has hit SA — will it be enough to kill the black market?
South Africa’s first generic semaglutide injection arrived in August, with many more expected. More competition should push ...
AllAfrica on MSN
The first generic weight loss drug hit South Africa in August - with many expected to follow. Will it be enough to kill the black market?
The first generic weight loss drug hit SA in August — with many expected to follow. Will it be enough to kill the black market?South Africa's first generic semaglutide injection arrived in August, ...
Mounjaro is now FDA-approved to lower heart attack risk in adults with type 2 diabetes who have a chance of developing these ...
Over a median follow-up of 210.1 weeks, tirzepatide was found to be noninferior to dulaglutide, with an 8% lower rate of MACE-3. The estimated hazard ratio for time to first MACE was 0.92 (95.3% CI, 0 ...
Everyday Health on MSN
These are the best telehealth companies for buying Foundayo online
Foundayo is the latest FDA-approved GLP-1. Here’s where you can get it online without leaving your house.
Who would pick up a coveted AFL All-Australian blazer if our three footy writers, Jake Michaels, Matt Walsh, and Jarryd Barca had their way? The 2026 season has concluded, so here's our final 23. B: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results